nytimes.com / .nytimes-com-science / Page 3

Commonwealth Fusion Systems, an M.I.T. spinoff, aims to generate carbon-free electricity in an industrial park near Richmond in the early 2030s.

Federal agencies have opened at least three reviews into whether the company and its leader complied with disclosure protocols intended to protect state secrets, people with knowledge of the matter said.

"It's taken us all aback," said a professor who led a study revealing that 37 people in a prehistoric site in England were likely consumed by their attackers.

President-elect Donald Trump's choice for health secretary has suggested that the polio vaccine cost more lives than it saved and that the vaccine did not wipe out the disease in the U.S.

A new rocket from Mr. Bezos' company Blue Origin and a satellite system from Amazon could heat up competition with SpaceX, owned by Mr. Musk.

The patient, Towana Looney, was in better health than previous recipients, and her case could signal progress toward solving the organ-supply shortage.

We tend to look at environmental problems in isolation. A holistic approach would be more effective, a new report says.

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.

People are turning to psilocybin, ketamine and other treatments for palliative care.

A hilarious new Broadway production asks: Can the superwoke vaxxers and anti-vaxxers at an elite private school learn to get along?